Pantoprazole Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-751

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 25021-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pan01 0005 01)

Structural Formula (Pan01 0005 01)
Chemical structure of the active ingredient pantoprazole sodium. The diagram illustrates the molecular arrangement and bonds characteristic of pantoprazole sodium used in the drug product.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pan01 0005 02)

Package Label – Principal Display Panel – Vial Label (Pan01 0005 02)
Label for Pantoprazole Sodium for Injection 40 mg per vial by Sagent Pharmaceuticals. The lyophilized powder is for intravenous infusion, single-dose vial, sterile and preservative-free. The label includes storage instructions, reconstitution details, lot and expiration date fields, and manufacturing information noting it is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.